ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity. [electronic resource]
Producer: 20200413Description: 130-135 p. digitalISSN:- 1476-4687
- Animals
- Carcinoma, Pancreatic Ductal -- drug therapy
- Dendritic Cells -- immunology
- Female
- Humans
- Immunity, Innate -- immunology
- Immunotherapy
- Interleukin-33 -- immunology
- Lymphocyte Activation
- Lymphocytes -- immunology
- Male
- Mice
- Mice, Inbred C57BL
- Pancreatic Neoplasms -- drug therapy
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- T-Lymphocytes -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.